These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35575284)

  • 1. A pilot study examining the efficacy of hochuekkito for improving quality of life in patients with myeloproliferative neoplasms.
    Edahiro Y; Koike M; Nojiri S; Harada Y; Gotoh A; Fujibayashi K; Nishizaki Y; Yanagisawa N; Takaku T; Nitta H; Tsukune Y; Misawa K; Kobayashi H; Komatsu N
    Jpn J Clin Oncol; 2022 Aug; 52(8):880-886. PubMed ID: 35575284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double blind placebo-controlled clinical trial of Hochuekkito, a traditional herbal medicine, in the treatment of elderly patients with weakness N of one and responder restricted design.
    Satoh N; Sakai S; Kogure T; Tahara E; Origasa H; Shimada Y; Kohoda K; Okubo T; Terasawa K
    Phytomedicine; 2005 Aug; 12(8):549-54. PubMed ID: 16121514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
    Emanuel RM; Dueck AC; Geyer HL; Kiladjian JJ; Slot S; Zweegman S; te Boekhorst PA; Commandeur S; Schouten HC; Sackmann F; Kerguelen Fuentes A; Hernández-Maraver D; Pahl HL; Griesshammer M; Stegelmann F; Doehner K; Lehmann T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Harrison CN; Radia D; Muxi P; Maldonado N; Besses C; Cervantes F; Johansson PL; Barbui T; Barosi G; Vannucchi AM; Passamonti F; Andreasson B; Ferrari ML; Rambaldi A; Samuelsson J; Birgegard G; Tefferi A; Mesa RA
    J Clin Oncol; 2012 Nov; 30(33):4098-103. PubMed ID: 23071245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EFFECTIVENESS OF HOCHUEKKITO (JAPANESE HERBAL MEDICINE) FOR GENERAL FATIGUE AFTER INTRODUCTION OF ENZALUTAMIDE IN THREE CASES OF CASTRATION-RESISTANT PROSTATE CANCER].
    Minagawa T; Domen T; Suzuki T; Ueno M; Nagai T; Ogawa T; Kiyokawa H; Ishizuka O
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(2):86-91. PubMed ID: 32307388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
    Geyer HL; Kosiorek H; Dueck AC; Scherber R; Slot S; Zweegman S; Te Boekhorst PA; Senyak Z; Schouten HC; Sackmann F; Fuentes AK; Hernández-Maraver D; Pahl HL; Griesshammer M; Stegelmann F; Döhner K; Lehmann T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Harrison CN; Radia D; Muxi P; Maldonado N; Besses C; Cervantes F; Johansson PL; Barbui T; Barosi G; Vannucchi AM; Paoli C; Passamonti F; Andreasson B; Ferrari ML; Rambaldi A; Samuelsson J; Cannon K; Birgegard G; Xiao Z; Xu Z; Zhang Y; Sun X; Xu J; Kiladjian JJ; Zhang P; Gale RP; Mesa RA
    Haematologica; 2017 Jan; 102(1):85-93. PubMed ID: 27540137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors.
    Mesa RA; Scherber RM; Geyer HL
    Leuk Lymphoma; 2015 Jul; 56(7):1989-99. PubMed ID: 25644746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies.
    Mazza GL; Kunze KL; Langlais BT; Kosiorek HE; DeWees TA; Geyer HL; Scherber RM; Mesa RA; Dueck AC
    Leuk Lymphoma; 2019 Jul; 60(7):1789-1795. PubMed ID: 30652523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of the Traditional Herbal Medicine, Gamiguibi-tang, in Patients With Cancer-Related Sleep Disturbance: A Prospective, Randomized, Wait-List-Controlled, Pilot Study.
    Lee JY; Oh HK; Ryu HS; Yoon SS; Eo W; Yoon SW
    Integr Cancer Ther; 2018 Jun; 17(2):524-530. PubMed ID: 29034740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot quasi-randomized controlled study of herbal medicine Hochuekkito as an adjunct to conventional treatment for progressed pulmonary Mycobacterium avium complex disease.
    Enomoto Y; Hagiwara E; Komatsu S; Nishihira R; Baba T; Kitamura H; Sekine A; Nakazawa A; Ogura T
    PLoS One; 2014; 9(8):e104411. PubMed ID: 25093868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytotherapy for Cachexia: Where Do We Stand?
    Kuchta K; Cameron S
    Front Pharmacol; 2020; 11():917. PubMed ID: 32733236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
    Geyer HL; Andreasson B; Kosiorek HE; Dueck AC; Scherber RM; Martin KA; Butler KA; Harrison CN; Radia DH; Cervantes F; Kiladjian JJ; Reiter A; Birgegard G; Passamonti F; Senyak Z; Vannucchi AM; Paoli C; Xiao Z; Samuelsson J; Mesa RA
    Cancer; 2016 Jun; 122(12):1888-96. PubMed ID: 27070130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?
    Langlais BT; Geyer H; Scherber R; Mesa RA; Dueck AC
    Leuk Lymphoma; 2019 Feb; 60(2):402-408. PubMed ID: 30033837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Hochuekkito on Physical Activity and Appetite in Postoperative Elderly Patients with Hip Fractures: A Randomized Controlled Trial.
    Watanabe M; Maeda J
    Prog Rehabil Med; 2022; 7():20220063. PubMed ID: 36561295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of exercise-based rehabilitation to patients with myeloproliferative neoplasms-An explorative study.
    Pedersen KM; Zangger G; Brochmann N; Grønfeldt BM; Zwisler AD; Hasselbalch HC; Tang LH
    Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12865. PubMed ID: 29888803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in MPN comes of age as a therapeutic target.
    Scherber RM; Geyer HL; Mesa RA
    Curr Hematol Malig Rep; 2014 Dec; 9(4):324-30. PubMed ID: 25262210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the effects of the three kinds of Kampo-hozai: Ninjinyoeito, Hochuekkito, and Juzentaihoto on anxious and low sociability behavior using NPY-knockout zebrafish.
    Kawabe M; Nishida T; Takahashi R; Inui A; Shiozaki K
    Front Pharmacol; 2023; 14():1168229. PubMed ID: 37324500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing symptom burden in myeloproliferative neoplasms.
    Tremblay D; Mesa R
    Best Pract Res Clin Haematol; 2022 Jun; 35(2):101372. PubMed ID: 36333066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms.
    Abelsson J; Andréasson B; Samuelsson J; Hultcrantz M; Ejerblad E; Johansson B; Emanuel R; Mesa R; Johansson P
    Leuk Lymphoma; 2013 Oct; 54(10):2226-30. PubMed ID: 23398206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between fatigue, physical activity, and QoL in patients with myeloproliferative neoplasms.
    Tolstrup Larsen R; Tang LH; Brochmann N; Meulengracht Flachs E; Illemann Christensen A; Hasselbalch HC; Zwisler AD
    Eur J Haematol; 2018 Jun; 100(6):550-559. PubMed ID: 29464777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms].
    Bao M; Shi DY; Shi HX; Liu XL; Duan MH; Zhuang JL; Du X; Qin L; Hui WH; Liang R; Wang MF; Chen Y; Li DY; Yang W; Tang GS; Zhang WH; Kuang X; Su W; Han YQ; Chen LM; Xu JH; Liu ZG; Huang J; Zhao CT; Tong HY; Hu JD; Chen CY; Chen XQ; Xiao ZJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):985-992. PubMed ID: 35045668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.